Kim E. Kortekaas, Nienke Solleveld‐Westerink, Basile Tessier‐Cloutier, Tessa Rutten et al.
AIMS: The most commonly mutated gene in vulvar squamous cell carcinoma (VSCC) is TP53 and its prognostic value, particularly in HPV-independent VSCC, is uncertain. In other tumours, p53 immunohistochemistry (IHC) is an excellent surrogate marker for TP53 mutations. In order to study this in VSCC, we...